CAC
DNMR

Cowen and Company’s Danimer Scientific, Inc. DNMR Stock Holding History

Cowen and Company’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-263
Closed -$103K – 534
2020
Q2 		$103K Buy
+263
New +$102K 0.02% 238

Other funds holding DNMR

FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.44% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Cowen and Company's DNMR Position: Q3 2020 in Review

Cowen and Company sold out of Danimer Scientific, Inc. (DNMR) in Q3 2020, closing a stake of 263 shares — an estimated $103K sold.

Cowen and Company first reported a position in DNMR in Q2 2020 and held it in 1 quarter. The position peaked at $103K in Q2 2020. 32 funds tracked by Wall St. Rank hold DNMR as of Q3 2020.

  • Cowen and Company reported no remaining Danimer Scientific, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cowen and Company sold 263 Danimer Scientific, Inc. shares in Q3 2020, an estimated $103K.
  • Cowen and Company first reported a position in Danimer Scientific, Inc. in Q2 2020 and held it in 1 quarter.
  • Cowen and Company's Danimer Scientific, Inc. position peaked at $103K in Q2 2020.
  • 32 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q3 2020.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.